Bruker | BRKR - Equity Capital And Reserves


Bruker reported $2.49B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
ABB USD 16.09B 95M Dec/2025
Agilent USD 6.74B 371M Sep/2025
Ametek USD 10.63B 101.91M Dec/2025
Bio Techne USD 2.01B 45.18M Dec/2025
Bio-Rad Laboratories USD 7.45B 716.8M Dec/2025
Bruker USD 2.49B 625.6M Sep/2025
Charles River Laboratories USD 3.16B 240.82M Dec/2025
Danaher USD 52.53B 1.46B Dec/2025
Exact Sciences USD 2.4B 100.37M Dec/2025
Fujikura JPY 507.01B 41.41B Dec/2025
Furukawa JPY 136.44B 3.99B Sep/2025
General Electric Aerospace USD 18.9B 86M Dec/2025
Hitachi JPY 6.36T 236.75B Dec/2025
Hologic USD 5.25B 197.2M Dec/2025
Illumina USD 2.72B 342M Dec/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Mettler Toledo International USD -23.64M 225.56M Dec/2025
Mitsubishi Electric JPY 4.16T 114.12B Dec/2025
Mitsubishi Heavy Industries JPY 2.65T 162.09B Dec/2025
Myriad Genetics USD 372.8M 15.3M Sep/2025
Nikon Corporation JPY 576.22B 77.13B Dec/2025
Olympus JPY 773.35B 39.77B Dec/2025
Repligen USD 2.11B 1.66B Dec/2025
Revvity USD 7.38B 180.27M Sep/2025
Smiths GBP 2.27B 168M Dec/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Waters USD 2.56B 230.55M Dec/2025